Opens in a new tab

CooperSurgical v European Distribution Center Motiva (CFI, 4 December 2025)

Date4 December 2025
CourtCFI
DivisionBrussels (BE) Local Division
Type of actionWithdrawal (RoP265)
Case number(s)UPC_CFI_415/2025
Registry referenceUPC_CFI_415/2025
PartiesCooperSurgical, Inc. v. European Distribution Center Motiva BVBA, Establishment Labs S.A. and PulseLavage AB

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In a decision of 4 December 2025, the Brussels Local Division allowed CooperSurgical to withdraw its infringement action (EP 3 302 292 B1), brought while an EPO opposition was pending, and ordered it to pay the defendants’ costs: EUR 105,757.90 to European Distribution Center Motiva and Establishment Labs, EUR 81,423.33 to PulseLavage. The decision shows the price of suing despite a negative preliminary opinion from the Opposition Division.

Question

Can a patentee that withdraws its action after the Opposition Division revokes the patent obtain an order that each party bear its own costs, on grounds of exceptional circumstances or unnecessary costs?

Decision

No. Suing during opposition proceedings is a fundamental right, which neither the UPCA nor the Rules prohibit, but a claimant that sues despite a negative preliminary opinion takes the risk. The defendants’ costs of defending the claim are not unnecessary (paragraphs 22 to 27). There were no exceptional circumstances: the withdrawal came two weeks after revocation, whereas a cautious claimant would have prepared for that outcome (paragraph 28). A withdrawing claimant is the unsuccessful party (paragraph 30). Costs must be reasonable, proportionate and proven. Assessing ex ante the value in dispute (EUR 4.25 million), the importance of the case, the stage of withdrawal and complexity, the division allowed EUR 100,000 in representation costs for the first two defendants, the EUR 400,000 ceiling applying to full proceedings (paragraphs 31 to 39).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 33(10) and 69
Rules of Procedure
Rules 152, 265 and 295(a)
Case law cited
Carrier v BITZER Electronics, Court of Appeal, 28 May 2024, Court of Appeal, UPC_CoA_232/2025, Fujifilm v Kodak, Düsseldorf Local Division (UPC_CFI_355/2025 and UPC_CFI_186/2025), OrthoApnea, Brussels Local Division, 25 July 2025

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Unitary patent, Local and central divisions (UPC).

Dhenne Avocats blog: The Transitional Period and the UPC: Coordinating Two Judicial Orders.

Publications by Matthieu Dhenne: Four Questions That Decide a UPC Market Entry, Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_415/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Withdrawal (RoP265)
Outcome (Dhenne Avocats summary)
Le retrait est autorisé et CooperSurgical, partie qui succombe, supporte les frais des défenderesses, fixés à 105 757,90 euros et 81 423,33 euros, sans circonstance exceptionnelle ni frais inutiles.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 302 292 B1Mentioned in the analysis (role not qualified)not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.